Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,349 | 53,602 | 113,447 | 35,267 | 22,063 |
| Marketable Securities | 164,065 | 144,280 | 118,227 | 93,028 | 32,068 |
| Receivables | 623 | 811 | 939 | 817 | 772 |
| TOTAL | $205,032 | $205,782 | $241,261 | $134,501 | $57,493 |
| Non-Current Assets | |||||
| PPE Net | 1,335 | 1,170 | 1,287 | 1,424 | 1,654 |
| Investments And Advances | 34,242 | 45,735 | 34,503 | 14,362 | 0 |
| Intangibles | 7,048 | 7,067 | 7,086 | 7,105 | 7,123 |
| Other Non-Current Assets | 3,554 | 3,740 | 3,909 | 4,007 | 4,514 |
| TOTAL | $46,179 | $57,712 | $46,785 | $26,898 | $13,291 |
| Total Assets | $251,211 | $263,494 | $288,046 | $161,399 | $70,784 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,985 | 7,564 | 4,244 | 7,292 | 5,254 |
| Accrued Expenses | 10,051 | 7,408 | 6,931 | 3,599 | 5,906 |
| TOTAL | $22,931 | $17,839 | $14,916 | $14,505 | $14,874 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 10,731 | 10,692 | 10,653 |
| Other Non-Current Liabilities | 30,572 | 28,707 | 28,217 | 23,541 | 7,240 |
| TOTAL | $30,939 | $29,074 | $39,315 | $34,600 | $18,260 |
| Total Liabilities | $53,870 | $46,913 | $54,231 | $49,105 | $33,134 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,275 | 61,227 | 61,216 | 52,107 | 51,804 |
| Common Shares | N/A | N/A | 1 | N/A | N/A |
| Retained earnings | -595,407 | -572,603 | -551,457 | -533,296 | -504,542 |
| Other shareholders' equity | -223 | -2 | -184 | -140 | -94 |
| TOTAL | $197,341 | $216,581 | $233,815 | $112,294 | $37,650 |
| Total Liabilities And Equity | $251,211 | $263,494 | $288,046 | $161,399 | $70,784 |